The creation of a regulatory-compliant cell bank is an essential component in the production of well characterised biopharmaceutical products. The use of qualified cell banks provides opportunity to detect and identify (and thereby exclude) possible contaminating adventitious agents such as viruses and mycoplasma prior to their use in manufacture.
Global biopharmaceutical companies are making a more significant commitment to outsourcing by striving to improve operating efficiency and increase pipeline productivity. Biotechnology companies and other private organizations have always preferred outsourcing to investing in internal infrastructure. Academic institutions are also partnering with biopharmaceutical companies to monetize innovation and acquire expertise in drug discovery and development.

Market Analysis and Insights: Global GMP Cell Banking Services Market
The global GMP Cell Banking Services market size is projected to reach US$ 258 million by 2027, from US$ 189.1 million in 2020, at a CAGR of 4.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global GMP Cell Banking Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global GMP Cell Banking Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global GMP Cell Banking Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global GMP Cell Banking Services market.

Global GMP Cell Banking Services Scope and Market Size
GMP Cell Banking Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global GMP Cell Banking Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mammalian
Microbial
Insect
Yeast
Avian
Stem Cell
Others

Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
WuXi AppTec
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Lonza
SGS Ltd
ViruSure
Austrianova
Goodwin Biotechnology
Paragon Bioservices
BioReliance
Sartorious
BSL Bioservice
Cleancells
Covance